VeTreat
Autonomous and Needle-Free Cattle Injection System
Company Overview
Snapshot
Founded in July 2024, VeTreat operates with 1–10 employees and is currently in the Pre-Funding stage. The company is developing an autonomous, AI-based, needle-free injection system for livestock, aiming to modernize animal treatment processes.
Business overview
VeTreat develops an autonomous, AI-based, needle-free injection system for livestock, specifically targeting cattle in dairy and beef operations. The core technology utilizes advanced computer vision and proprietary AI, developed under the NVIDIA Inception program, to identify animals, select optimal injection sites, and administer precise dosages without human involvement. This system enhances accuracy, animal welfare, and operational efficiency by reducing risks to farm workers, lowering operational costs, and ensuring consistent, traceable treatment data. VeTreat operates within the Agriculture & Food Technologies sector, focusing on farm equipment and treatment, and leverages technologies such as industrial robotics, biometrics, computer vision, and cloud computing to serve the livestock industry.
Log in to access full profile ›Company Intelligence Q&A
- What is VeTreat's primary product?
- VeTreat's primary product is the VeTreat CowCare, an autonomous, AI-based, needle-free injection system designed for livestock, initially focusing on cattle in dairy and beef operations.
- When was VeTreat founded?
- VeTreat was founded in July 2024.
- What technology does VeTreat utilize for its injection system?
- VeTreat utilizes advanced computer vision and proprietary AI, developed under the NVIDIA Inception program, to identify animals, select optimal injection sites, and administer precise dosages.
- Which markets does VeTreat target?
- VeTreat targets geomarkets including Australia, Europe, Israel, Canada, South America, and the United States.
- What is the current product stage of VeTreat's solution?
- VeTreat's product, the VeTreat CowCare, is currently in the Research and Development (R&D) stage, with development ongoing since the company's founding in July 2024.